HiveProspectStranded Biotech Asset IntelligenceResearch intelligence
Research workspace tools

RVU120

TERMINATED · PHASE1, PHASE2 · Advanced Solid Tumor

Sponsor decision

Registry source

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.